Estefanía Zapata-Bravo

Estefanía Zapata-Bravo

Auto-generated profile, based on publicly available information

Estefanía Zapata-Bravo

Neuroscience Research Group (NEUROS). Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Carrera 24 # 63C - 69, Bogotá, Colombia

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 October 2021 in Systematic Reviews
Verified
Journal Article
Open access
PDF file
JMJuliana Muñoz-Ortiz
Juliana Muñoz-Ortiz
JRJuliana Reyes-Guanes
Juliana Reyes-Guanes
EZEstefanía Zapata-Bravo
Estefanía Zapata-Bravo
LMLaura Mora-Muñoz
Laura Mora-Muñoz
JRJuan Antonio Reyes-Hurtado
Juan Antonio Reyes-Hurtado
ADAlejandra de-la-Torre
Alejandra de-la-Torre
Purpose: The aim of this study was to review the scientific evidence and describe the ocular treatment-emergent adverse events (TEAEs) related to pharmacological treatment in patients with multiple sclerosis. Methods: A systematic review of literature was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-analysis guidelines in the MEDLINE, LILACS, EMBASE, and COCHRANE databases. Articles were filtered based on title and abstract considering the selection criteria and subsequently filtered by full-text reading. The resulting articles were evaluated using the Joanna Briggs Institute Quality Tools. Study characteristics and results were extracted and presented in structured tables to conduct a narrative synthesis. Results: A total of 2852 published articles were extracted using our strategy. After removing duplicates, 2841 articles were screened based on title and abstract, 102 articles were evaluated using quality tools, and 69 articles were filtered by full-text reading. Through this search strategy, 60 articles met all the inclusion criteria and seven articles, through a search update conducted in the same manner, were included. This resulted in 67 articles meeting the inclusion criteria, of which 11 were experimental and 56 were observational. The therapies related to ocular TEAEs were alemtuzumab, amantadine, fingolimod, steroids, CTLA-4 Ig, estriol, interferon β, natalizumab, hyperbaric oxygen, rituximab, siponimod, teriflunomide, and tovaxin. Fingolimod and siponimod were commonly associated with macular edema, interferon β was associated with retinopathy, alemtuzumab was associated with thyroid eye disease, amantadine was associated with corneal edema, and steroids were associated with acute retinal necrosis. Opportunistic infections were also found, and there was one life-threatening case. Conclusions: Our search revealed different methodological assessments of the topic. However, longitudinal studies regarding ocular TEAEs related to multiple sclerosis therapy are necessary to provide evidence-based recommendations, especially in understudied regions such as Latin America and Africa. Physicians should monitor ocular symptoms in patients being treated for multiple sclerosis and consider an interdisciplinary approach. Systematic review registration: PROSPERO ID CRD42020106886

18 February 2022 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
CGCarlos Humberto Cifuentes González
Carlos Humberto Cifuentes González
EZEstefanía Zapata-Bravo
Estefanía Zapata-Bravo
MSMaría Camila Sierra-Cote
María Camila Sierra-Cote
LBLaura Boada-Robayo
Laura Boada-Robayo
ÁVÁngela Paola Vargas-Largo
Ángela Paola Vargas-Largo
ADAlejandra de-la-Torre
Alejandra de-la-Torre
This study aims to describe the incidence of ocular involvement in patients with toxoplasmosis and describe the sociodemographic characteristics by age, sex, and region in Colombia, based on the National Health Registry of data between January 1, 2015, and December 31, 2019. We conducted a cross-sectional study using the Integrated Social Protection Information System database from the Colombian Ministry of Health, the unique official database in the country. We used the International Classification of Diseases for all codes of toxoplasmosis with a specific filter for ocular toxoplasmosis (OT) from 2015 to 2019 to estimate the incidence and the demographic status of the disease in Colombia. During the 5 years of study, the crude unadjusted incidence of OT was 42.02 (Confidence Interval 30.29-56.19) cases in 1,000 patients with toxoplasmosis per year, showing a significant increase of incidence when comparing the year 2019 to the year 2015. There was a predominance of female patients (58% of the cases). The distribution by age shows an increase in cases of the disease in subjects aged 15 to 49 years (65.2%). The geographic analysis showed a higher proportion of cases in the Andean region, followed by the Pacific and the Atlantic regions. This is the first study that determines the epidemiological characteristics of OT based on a National Health database in Colombia, showing a public health problem and evidencing the neediness of solidifying preventive and screening strategies in the Colombian population.

17 October 2026 in Environmental Toxicology
Verified
Journal Article
Open access
PDF file
DNDiana M. Narváez
Diana M. Narváez
JLJuliana Lago
Juliana Lago
CTCarlos Enrique Trillos-Peña
Carlos Enrique Trillos-Peña
MVMarcela Varona
Marcela Varona
LALeonardo Briceño Ayala
Leonardo Briceño Ayala
HGHelena Groot
Helena Groot
Epidemiological studies have demonstrated a link between chronic kidney disease (CKD) and environmental mercury (Hg) exposure. Colombia has a well‐documented history of artisanal and small‐scale gold mining, where Hg exposure affects miners and nearby riverside and urban populations. This study aimed to evaluate the effects of polymorphisms in GSTM1 , GSTT1 , MT1A (rs8052394), and MT2A (rs10636) on Hg levels and their relationship with end‐stage renal disease (ESRD) in a Colombian urban population. We conducted a cross‐sectional, multicenter exploratory study on 401 CKD patients to assess the impact of polymorphisms on total Hg (tHg) levels in blood and hair, and their relationship with ESRD. Patients were divided into two groups: Group 1 (G1) with patients in Stages 1–4 CKD, and Group 2 (G2) with patients in Stage 5 CKD. Unexpectedly, tHg levels were low in our population (GM (SD) = 0.69 (2.07) and 0.73 (2.18) μg/L in blood, and GM (SD) = 0.22 (3.80) and 0.18 (2.9) μg/g in hair for G1 and G2, respectively). We found that low hair tHg levels were significantly associated with null GSTT1 , double null GSTM1/GSTT1 , and MT1A (rs8052394) GG genotype in G1, and high tHg with the null GSTM1 genotype in G2 patients. Furthermore , when pooling G1 and G2, the double‐null genotype of GSTM1 / GSTT1 , as well as MT1A (rs8052394) AA and MT2A (rs10636) GC, were more prevalent among patients with hair and blood tHg levels exceeding 1 μg/g and 5 μg/L, respectively. Patients carrying the MT1A (rs8052394) AG genotype exhibited an increased risk of ESRD. In conclusion, our findings suggest that, even in a population with low Hg exposure, polymorphisms in glutathione S‐transferases and metallothioneins showed stage‐specific associations with hair tHg levels, and that MT1A may contribute to ESRD risk.

6 May 2022 in Salud UIS
Verified
Journal Article
Open access
PDF file
SDSonia Díaz
Sonia Díaz
ETEliana M. Téllez
Eliana M. Téllez
RPRuth M. Palma
Ruth M. Palma
EZEstefanía Zapata
Estefanía Zapata
LALeonardo Briceño Ayala
Leonardo Briceño Ayala
CTCarlos Enrique Trillos-Peña
Carlos Enrique Trillos-Peña
Introducción: el mercurio circula por el aire; persiste en suelos, sedimentos y agua, y causa efectos en la salud humana. Las mujeres en edad fértil y los neonatos son la población más vulnerable. Objetivo: analizar las evidencias sobre la carga de enfermedad ocasionada por la exposición a mercurio, así como el impacto económico sobre el sistema de salud. Metodología: revisión de alcance de la literatura, de las bases de datos PUBMED y EPISTEMONIKOS, búsqueda manual de documentos técnicos de entidades oficiales de diferentes continentes. Resultados: se identificaron 311 registros en bases de datos y 4 en búsqueda manual en entidades oficiales; 19 artículos fueron incluidos. Discusión: predomina la afectación del desarrollo neurológico y cognitivo en niños de madres expuestas y lactantes. Los costos se midieron por la pérdida del coeficiente intelectual. Conclusión: efectos en salud por la exposición a metilmercurio se traducen en gastos para la sociedad y los sistemas de salud.